67.04
전일 마감가:
$67.81
열려 있는:
$68
하루 거래량:
1.50M
Relative Volume:
1.13
시가총액:
$5.19B
수익:
$646.34M
순이익/손실:
$-512.40M
주가수익비율:
-10.03
EPS:
-6.6871
순현금흐름:
$202.76M
1주 성능:
+8.02%
1개월 성능:
+23.01%
6개월 성능:
+39.67%
1년 성능:
+76.42%
Hinge Health Inc Stock (HNGE) Company Profile
명칭
Hinge Health Inc
전화
415-689-8429
주소
455 MARKET STREET, SAN FRANCISCO
Compare HNGE vs VEEV, BTSG, TEM, HQY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
HNGE
Hinge Health Inc
|
67.04 | 5.29B | 646.34M | -512.40M | 202.76M | -6.6871 |
|
VEEV
Veeva Systems Inc
|
154.85 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
64.43 | 12.58B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
48.79 | 9.39B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
86.33 | 7.27B | 1.34B | 230.70M | 440.96M | 2.6695 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 개시 | Wells Fargo | Overweight |
| 2025-09-05 | 개시 | Robert W. Baird | Neutral |
| 2025-07-14 | 개시 | Citizens JMP | Mkt Outperform |
| 2025-06-16 | 개시 | Barclays | Overweight |
| 2025-06-16 | 개시 | BofA Securities | Buy |
| 2025-06-16 | 개시 | Canaccord Genuity | Buy |
| 2025-06-16 | 개시 | Evercore ISI | Outperform |
| 2025-06-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-06-16 | 개시 | Morgan Stanley | Overweight |
| 2025-06-16 | 개시 | Needham | Buy |
| 2025-06-16 | 개시 | Piper Sandler | Overweight |
| 2025-06-16 | 개시 | RBC Capital Mkts | Outperform |
| 2025-06-16 | 개시 | Raymond James | Outperform |
| 2025-06-16 | 개시 | Stifel | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-06-16 | 개시 | William Blair | Outperform |
모두보기
Hinge Health Inc 주식(HNGE)의 최신 뉴스
Alkeon Capital Management LLC Purchases 415,093 Shares of Hinge Health Inc. $HNGE - MarketBeat
HNGE Maintains by Raymond James -- Price Target Raised to $80 - GuruFocus
Hinge Health expands HingeSelect to offer end-to-end MSK surgical care - MSN
Canaccord raises Hinge Health stock price target on growth outlook By Investing.com - Investing.com Canada
Canaccord raises Hinge Health stock price target on growth outlook - Investing.com
Hinge Health (HNGE) Stock Valuation Split Between Bearish Narrative And Optimistic Cash Flow Outlook - Yahoo Finance
Bullseye Asset Management LLC Acquires Shares of 41,763 Hinge Health Inc. $HNGE - MarketBeat
Hinge Health, Inc. (HNGE) Analyst/Investor DaySlideshow (NYSE:HNGE) 2026-06-13 - Seeking Alpha
Needham raises Hinge Health stock price target on guidance boost By Investing.com - Investing.com Nigeria
HNGE Maintained by Keybanc -- Price Target Raised to $90.00 - GuruFocus
Is Hinge Health a Stock to Sell After an Insider Sold 50,000 Shares? - Yahoo Finance
Bessemer funds tied to Hinge Health (NASDAQ: HNGE) report June share sales - Stock Titan
Is Hinge Health a Stock to Sell After an Insider Sold 50,000 Shares? - The Motley Fool
KeyBanc raises Hinge Health stock price target on surgery expansion By Investing.com - Investing.com Australia
KeyBanc raises Hinge Health stock price target on surgery expansion - Investing.com
Citizens maintains Hinge Health stock rating on customer conference By Investing.com - Investing.com Australia
Citizens maintains Hinge Health stock rating on customer conference - Investing.com UK
Hinge Health stock hits all-time high at 66.6 USD By Investing.com - Investing.com Nigeria
RBC Capital Maintains Hinge Health(HNGE.US) With Buy Rating, Raises Target Price to $75 - Moomoo
HNGE Maintained by RBC Capital -- Price Target Raised to $75.00 - GuruFocus
Hinge Health stock hits all-time high at 66.6 USD - Investing.com
HNGE Maintained by Truist Securities -- Price Target Raised to $85 - GuruFocus
Hinge Health's New Products, Margin Gains Support Growth Outlook, RBC Says - Moomoo
Truist raises Hinge Health stock price target on growth outlook By Investing.com - Investing.com Australia
HNGE Maintained by Barclays -- Price Target Raised to $70 - GuruFocus
Hinge Health (NYSE:HNGE) Price Target Raised to $85.00 at Truist Financial - MarketBeat
Hinge Health Is Maintained at Outperform by RBC Capital - Moomoo
Truist raises Hinge Health stock price target on growth outlook - Investing.com
Hinge Health Expands HingeSelect to Offer End-to-End MSK Surgical Care - Zacks Investment Research
Truist Raises Price Target on Hinge Health to $85 From $79, Keeps Buy Rating - Moomoo
A Quick Look at Today's Ratings for Hinge Health(HNGE.US), With a Forecast Between $65 to $85 - Moomoo
HNGE Maintains Buy Rating -- Price Target Raised to $76.00 by Ne - GuruFocus
Hinge Health raises Q2 and FY 2026 guidance; projects above estimate - MSN
Stifel reiterates Hinge Health stock rating on surgical expansion - Investing.com UK
Needham & Company LLC Increases Hinge Health (NYSE:HNGE) Price Target to $76.00 - MarketBeat
Stifel reiterates Hinge Health stock rating on surgical expansion By Investing.com - Investing.com Australia
Needham raises Hinge Health stock price target on guidance boost - Investing.com
RBC Raises Price Target on Hinge Health to $75 From $65, Keeps Outperform Rating - marketscreener.com
RBC Capital raises Hinge Health stock price target on guidance boost By Investing.com - Investing.com South Africa
RBC Capital raises Hinge Health stock price target on guidance boost - Investing.com
Hinge Health Inc (HNGE) PT Raised to $76 at Needham - StreetInsider
Hinge Health Inc (HNGE) PT Raised to $75 at RBC Capital - StreetInsider
HNGE: Unified care platform, AI-driven growth, and new products fuel strong financial outperformance - TradingView
Hinge Health adds surgery to HingeSelect, delivering a fully integrated musculoskeletal care platform - 01net
Piper Sandler reiterates Hinge Health stock rating at Overweight By Investing.com - Investing.com Nigeria
Piper Sandler reiterates Hinge Health stock rating at Overweight - Investing.com
Hinge Health Inc (HNGE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):